Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance

By Nakano Takashi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 6, 2013-06 ,pp. : 469-477

Informa Healthcare

Access to resources Recommend Favorite

Anagrelide for the Treatment of Thrombocythaemia in Daily Clinical Practice: A Post-Marketing Observational Survey on Efficacy and Safety Performed in Germany

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 39-44

Karger

Access to resources Recommend Favorite

Epidemiological data, efficacy and safety of a paracetamol––tramadol fixed combination in the treatment of moderate-to-severe pain. SALZA: a post-marketing study in general practice

By Mejjad O.   Serrie A.   Ganry H.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1013-1020

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of mirabegron as ‘add‐on’ therapy in patients with overactive bladder treated with solifenacin: a post‐marketing, open‐label study in Japan (MILAI study)

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

By  

International Journal of Healthcare Information Systems and Informatics (IJHISI), Vol. 2, Iss. 3, 2007-07 ,pp. : 65-80

IGI Global_journal

Access to resources Recommend Favorite